- Ongoing, recruitingTherapeutic exploratory (Phase II)
(22138) A randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of BAY 3018250 in patients with symptomatic proximal deep vein thrombosis
This study is testing a new medicine, BAY 3018250, for blood clots in deep veins (DVT) in the legs. We want to see if it helps break down clots and reduce leg pain, while also checking for any serious side effects like bleeding.
For: Thrombolysis of symptomatic proximal vein thrombosisGermany · France · Belgium - Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
(21751) First-in-human single dose escalation study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of BAY 3018250 in healthy men in a randomized, placebo-controlled, single-blind, group-comparison design
This early-stage study is looking at a new medicine called BAY 3018250 for treating strokes. It's the very first time this medicine is being given to people. We want to check if it's safe and how the body handles it in healthy men.
For: Acute ischemic strokeGermany